Note: Ingredients listed on restricted chemical lists
EC/CAS
259-174-3/54464-57-2
Name of the chemical
1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one (40)
Concentration
<0,5%
EC/CAS
201-134-4/78-70-6
Name of the chemical
1,6-Octadien-3-ol, 3,7-dimethyl
Concentration
<0,15%
EC/CAS
204-116-4/115-95-7
Name of the chemical
3,7-Dimethyl octa-1,6-diene-3-yl acetate (40)
Concentration
<0,15%
General Information
Version
2.0/EN
Revision date
2022-06-27
Product name
Dr. Marcus Aromatherapy Relax
Manufacturer Name
Dr. MARCUS International Sp. z o.o.
Icons in SDS
Company Information
company name
Dr. MARCUS International Sp. z o.o.
e-mail address of the competent person responsible for the Safety Data Sheet
drmarcus@dr-marcus.com
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Aquatic Chronic 3 H412 Harmful to aquatic life with long lasting effects.
2.2 Label elements
Hazard pictograms and signal words None. Hazardous components placed on the label None.
Hazard statements
H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P273 Avoid release to the environment. P501 Dispose of contents/container to properly labelled waste containers according to national law.
Additional information
EUH208 Contains linalyl acetate; linalool; 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan- 1-one. May produce an allergic reaction.
2.3 Other hazards
Product does not contain components, which meet criteria for PBT or vPvB in accordance with Annex XIII of REACH Regulation. The product does not contain substances included in the list established in accordance with Article 59(1) for having endocrine disrupting properties, or substances identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 (3) or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % by weight.
